Stock Talk
Oncolytics Biotech, Inc. (ONCY): $1 stock (for now)
There is a new trial, just started, against Pancreatic Cancer. Without fanfare, just a brief item in the news to announce that the first patient being dosed in the Pelareorep or "Pela" trial. It is no longer in "planning status". The rubber met the road this week. "First patient dosed".
_______
"Pelareorep, also known as Reolysin, is a propietary formulation of the reovirus which is a naturally occurring virus that can infect and kill cancer cells. It is being developed by Oncolytics Biotech Inc, for the treatment of various types of cancer. The therapy works by selectively targeting and replicating within cancer cells, therby enhancing the anti-tumor immune response. This dual mechanism of action has shown promise in preclinical and clinical studies, particularly when combined with other cancer therapies such as checkpoint inhibitors and chemotherapy." - AI- Chat GPT.
_______
Jones report view: ONCY holds all the patents on Pelareorep. For risk aware investors holding a few shares of ONCY, at just over a buck a share may pay off in a big way as Pelareorep advances further. Several upcoming studies are in planning to further confirm the Mechanism of Action (MoA). Yes, it's all about confirming the MoA in several cancer indications. Pancreatic cancer is the ultimate test. If the Pela and the checkpoint inhibitor shows similar or better results than past studies, where a Complete Response (CR) was reported. Yes, watch ONCY stock and be respectful to the fighters. This is a very challenging endeavor, and us small investors should stay aware of the risk of the biotech arena.
Astute investors should perhaps also stay aware of progress reports from this new Pancreatic trial study. What "If " the new Pela treatment protocol succeeds against Pancreatic Cancer???
Caveat: Such an endeavor has NEVER been easy.
Key point: Treatment progress does not necessarily take "years" to know how a patient is responding. Past "Pela" studies show responses in terms of weeks - not years.
Could this new combo treatment with "Pela" and the recommended by "Pan Can" checkpoint inhibitor and a modified Chemo be the key to breaking the grip of PC?
God bless the fighters.
Stay tuned for more on Stocks to Watch.
For now, we close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time. But trying to look ahead a few months into the future may be a way to do things. If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. In all - we use the word maybe "some", not "too much" and play it accordingly. Remember never get arrogant in our various notions because things do change in the market and individual stocks are subject to many factors outside of our control.. So we try to -stay aware.
With all the above caveats and attempted prognostications, I will close this post. Stay tuned for more opining on the market and stocks to watch.
_____________
